#ThinkSabio Latest News
Phase 3 COMP005 trial in participants with treatment resistant depression (TRD) 6-week topline data on track for Q2
Phase 3 COMP005 trial in participants with treatment resistant depression (TRD) 6-week topline data on track for Q2